TY - JOUR AU - Tariq, Saba AU - Tariq, Sundus AU - Hussain, Shaista AU - Baig, Mukhtiar PY - 2020/08/20 Y2 - 2024/03/29 TI - Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker JF - Pakistan Journal of Medical Sciences JA - Pak J Med Sci VL - 36 IS - 6 SE - Original Articles DO - 10.12669/pjms.36.6.2678 UR - https://pjms.org.pk/index.php/pjms/article/view/2678 SP - AB - Objective: To determine the association of serum osteoprotegerin (OPG) with the severity of chronic liver disease in female patients.Methods: This case-control study was conducted in Madina Teaching Hospital from 2019-2020.An institutional review board of University Medical and Dental College, The University of Faisalabad gave the approval to conduct the study. Only female patients of age group 40 to 60 years having CLD were included in this study. Total 80 participants were enrolled after fulfilling the inclusion and exclusion criteria. Serum OPG levels were measured by enzyme linked immunosorbant assay (ELISA) supplied by ELAB Sciences, USA. The severity of disease was assessed by Child-Pugh classification.Results: OPG levels were significantly different between the three Child-Pugh classes. OPG levels were significantly high in class C indicating increased level of this cytokine in CLD as compared to class A (p = <0.05). There was a positive association of OPG with splenomegaly (OR = 2.10, p = <0.001), hepatomegaly (OR = 4.41, (p = < 0.05), skin pigmentation (OR = 2.06, p = <0.05), malena (OR = 1.87, p = <0.05) and prolonged bleeding (OR = 1.86, p = <0.05).Conclusion: The levels of serum Osteoprotegerin is increased in severe form of chronic liver disease (Class C) of Child-Pughs classification as compared to mild (Class A) and moderate (Class B) forms of Child-Pughs classification.doi: https://doi.org/10.12669/pjms.36.6.2678How to cite this:Tariq S, Tariq S, Hussain S, Baig M. Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker. Pak J Med Sci. 2020;36(6):1325-1329. doi: https://doi.org/10.12669/pjms.36.6.2678This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ER -